Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and challenges
Authors:
Open Access
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 486, 29-37
Abstract
No abstract availableKeywords
Funding Information
- Irish Research Council
This publication has 91 references indexed in Scilit:
- XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cellsCell Research, 2013
- PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1α-mediated unfolded protein responseNature Cell Biology, 2012
- Intricately Regulated: A Cellular Toolbox for Fine-Tuning XBP1 Expression and ActivityCells, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- IRE1α Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell FatesCell, 2009
- GPR30: A G protein-coupled receptor for estrogenMolecular and Cellular Endocrinology, 2007
- Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1Cell, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNANature, 2002
- XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription FactorCell, 2001